Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10041784HBVENSG00000097007.20protein_codingABL1YesNo25P00519
TVIS10041785HBVENSG00000097007.20protein_codingABL1YesNo25P00519
TVIS30009838HIVENSG00000097007.20protein_codingABL1YesNo25P00519
TVIS30011116HIVENSG00000097007.20protein_codingABL1YesNo25P00519
TVIS30016681HIVENSG00000097007.20protein_codingABL1YesNo25P00519
TVIS30016680HIVENSG00000097007.20protein_codingABL1YesNo25P00519
TVIS30009839HIVENSG00000097007.20protein_codingABL1YesNo25P00519
TVIS30085762HIVENSG00000097007.20protein_codingABL1YesNo25P00519
TVIS30072171HIVENSG00000097007.20protein_codingABL1YesNo25P00519
TVIS30072172HIVENSG00000097007.20protein_codingABL1YesNo25P00519
TCGA Plot Options
Drug Information
GeneABL1
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0000014
UniProt IDP00519
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830